Stereotaxis Announces the First Graduating Class of the Robotic Electrophysiology Fellows Program
Established in 2018, the Robotic Electrophysiology Fellows Program currently is active at 18 leading medical centers globally and has enrolled 34 electrophysiology fellows. The 2019 graduates of the Robotic Electrophysiology Fellows Program include:
Ernesto Betancourt , M.D. –Barnes-Jewish Hospital atWashington University School of Medicine Steven Hamilton , M.D. –Oklahoma University Health Sciences Center Todd Kobrinski , M.D. –Mount Sinai St. Luke’s HospitalAsad Mohammad , M.D. –Mount Sinai St. Luke’s HospitalMiriam Muller , M.D. –Oulu University - Yelemessov Nurlan, M.D. –
Novosibirsk Institute Sandeep Sodhi , M.D. –Barnes-Jewish Hospital atWashington University School of Medicine Daniel Sohinki , M.D. –Oklahoma University Health Sciences Center Keith Suarez , M.D. –Baylor Scott &White Medical Center Douglas Wan , M.D. –Sunnybrook Health Sciences Centre
“We congratulate the pioneering Robotic EP Fellows Class of 2019,” said
About the Robotic Electrophysiology Fellows Program
The Robotic Electrophysiology Fellows Program is an optional addition to a traditional electrophysiology fellowship, allowing forward-thinking electrophysiology fellows to augment their clinical and career development through mastery of robotic skill sets. The program includes hands-on didactic training, navigation simulator training, and live case training. It may be enhanced with additional components such as hands-on heart anatomy sessions, interactions with other fellows enrolled in the program, and participation in meetings of the
About
This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe”, "estimate”, "project”, "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, the Company's ability to raise additional capital on a timely basis and on terms that are acceptable, its ability to continue to manage expenses and cash burn rate at sustainable levels, its ability to continue to work with lenders to extend, repay or refinance indebtedness, or to obtain additional financing, in either case on acceptable terms, continued acceptance of the Company's products in the marketplace, the effect of global economic conditions on the ability and willingness of customers to purchase its systems and the timing of such purchases, competitive factors, changes resulting from healthcare reform in
Company Contact:
Chairman and Chief Executive Officer
Chief Financial Officer
314-678-6100
investors@stereotaxis.com